Raman Venkataramanan

University of Pittsburgh — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index208citations16works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phytochemical compounds biological activities(9), PI3K/AKT/mTOR signaling in cancer(3), Pharmacological Effects and Toxicity Studies(3), Pregnancy and preeclampsia studies(1), Renal Transplantation Outcomes and Treatments(1)

Publications16 total

Pharmacogenomics of buprenorphine - a narrative review
Pharmacogenomics·2025Open Access
Supplementary Table 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 3 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Table 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 2 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 3 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 1 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Data from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Data from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
Supplementary Figure 2 from mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
2023Open Access
mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
UNC Libraries·2020Open Access
Tacrolimus Analysis
Therapeutic Drug Monitoring·1995· 29 citedOpen Access
FK506 and pregnancy in liver transplant patients.
PubMed·1993· 47 cited
Pharmacokinetics of Ceftriaxone in Liver‐Transplant Recipients
The Journal of Clinical Pharmacology·1991· 16 cited
THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVER
Transplantation·1991· 116 cited

Frequent Co-authors

Debasmita Roy(11), Sang‐Hoon Sin(11), Amy Lucas(11), Anthony B. Eason(11), Veenadhari Chavakula(11), Isaac B. Hilton(11), Kristen M. Tamburro(11), Blossom Damania(11), Dirk P. Dittmer(11), Ling Wang(9), John J. Fung(3), Vijay Warty(3), Ashok Jain(2), Thomas E. Starzl(2), Thomas E. Starzl(2), Ling Wang(2), Kareem Abu‐Elmagd(1), M Alessiani(1), S Takaya(1), Satoru Todo(1)